Asthma Navigator Intervention to Improve Health Equity in Children

Not Applicable

Recruiting

• Conditions: Asthma in Children
• Interventions: Behavioral: The asthma navigator

• Registration Number: NCT06513832
• Lead Sponsor: Emory University

Brief Summary

The goal of this study is to improve health equity in children aged 5-16.9 years admitted to the PICU for asthma. The objectives are:

* To identify the factors related to differential experiences of asthma self-management

* To pilot the effectiveness of an individualized asthma navigator intervention at PICU discharge.

Detailed Description

Despite available asthma treatments, nearly 50% of children with asthma experience exacerbations annually, with disadvantaged children, particularly Black and Hispanic, being the most affected. These disparities are largely due to social determinants of health (SDOH), including socioeconomics and family hardship, which explain over 80% of the racial disparities in asthma outcomes. Children in lower opportunity neighborhoods face additional challenges like poor housing and limited green spaces, increasing exposure to pollutants and allergens.

At Children's Healthcare of Atlanta's Pediatric ICU (PICU), 85% of asthma admissions come from low-opportunity areas, with 36.7% having another exacerbation within a year. Significant barriers to better outcomes include limited provider understanding of SDOH and challenges in asthma self-management. Effective asthma self-management, supported by medical providers, is crucial for improving health outcomes in these disadvantaged children.

Study Timeline

• Study First Submitted: 2024-07-15
• Study First Submitted QC: 2024-07-19
• Study First Posted: 2024-07-22
• Status Verified: 2025-01
• Study Start: 2025-01-17
• Last Update Submitted: 2025-01-22
• Last Update Posted: 2025-01-23
• Primary Completion: 2026-08
• Study Completion: 2026-08

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

• Admitted to the PICU for asthma

Exclusion Criteria

• Cystic fibrosis
• Immune deficiency
• Prematurity <35 weeks
• Gestation and congenital airway deformities
• Non-English speaker

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
The Asthma Navigator	The asthma navigator	The Children's electronic medical record (EMR) of each child will be screened weekly for up to 52 weeks. When an asthma exacerbation prompting unscheduled healthcare utilization is noted (primary outcome), or at the end of 52 weeks, participant involvement in the study will end.

Primary Outcome Measures

Name	Time	Method
Future unscheduled healthcare utilization for asthma exacerbation	Baseline, end of study (average of 52 weeks)	The occurrence of unscheduled healthcare utilization and the date and time of occurrence will be assessed through weekly screenings of each child's EMR at Children's (Epic system).

Trial Locations

Locations (1)

Children's Healthcare of Atlanta; 🇺🇸 Atlanta, Georgia, United States